CLINICAL_TRIALS
trial_result
· 2017-11-20
Clinical Trial Update: Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients
Summary
Terminated clinical trial evaluating whether adrenomedullin can detect pancreatic cancer in patients with new-onset diabetes. The study was sponsored by the Uni…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Roma La Sapienza | Conditions: Diabetes Mellitus, Adult-Onset, Diabetes Complications | Status: TERMINATED